Having made its first foreign acquisition earlier this year, Cipla Ltd, India’s second largest drug maker by market share, is planning to go global, Mint reported. The report added that Cipla is looking to establish a direct presence in all overseas market. To achieve this target, it has put in place a top management team. The team comprises MD and global chief executive officer Subhanu Saxena, new chief financial officer (global) Rajesh Garg, head of international business Christos Kartalis, the newly posted heads of the US and European businesses, Frank Pieters and Tim Crew; global legal head Murali Neelakantan; global biologicals head Steven Lehrer, CEO of the newly acquired overseas subsidiary Cipla Medpro South Africa Ltd, Paul Miller.

Read the complete report here